Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768599 · ClinicalTrials.gov registry record · Phase 2
A Study of Econazole Foam 1% in Athlete's Foot
A Phase 2 study of Tinea Pedis and Athlete's Foot, sponsored by AmDerma.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 6
- Study locations
NCT00768599 is a Phase 2 study of Tinea Pedis and Athlete's Foot that has completed, run by AmDerma. The registered enrollment target is 135 participants, below the 312-participant average among 9 other Tinea Pedis trials with a reported enrollment target (57% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT00768599, a Phase 2 study of Tinea Pedis and Athlete's Foot, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescribe to treat athlete's foot. This study will help to understand if the foam works the same as the cream to treat athlete's foot.
Conditions Studied
Interventions
- DRUG Econazole Nitrate Cream 1%
- DRUG Econazole Nitrate Foam 1%
- DRUG Vehicle Foam
Study Locations (6)
California
- Stacy Smith, MD - San Diego
Michigan
- Daniel Stewart, DO - Clinton Township
Minnesota
- Steven Kempers, MD - Fridley
Tennessee
- Michael Gold, MD - Nashville
Texas
- Michael Jarratt, MD - Austin
Utah
- Leonard Swinyer, MD - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00768599
The ClinicalTrials.gov registry entry for NCT00768599 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 312-participant average among 9 other Tinea Pedis trials with a reported enrollment target (57% lower). The listed sponsor is AmDerma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tinea Pedis appearing as the primary indexed condition, and to 3 interventions - of which Econazole Nitrate Cream 1% is the first listed.
NCT00768599 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00768599 about?
NCT00768599 is a clinical study titled "A Study of Econazole Foam 1% in Athlete's Foot". This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescrib...
What is the current status of trial NCT00768599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2008-03. Estimated completion is 2008-10.
What conditions does trial NCT00768599 study?
This clinical trial studies the following conditions: Tinea Pedis, Athlete's Foot.
What interventions are being tested in trial NCT00768599?
The interventions under investigation include: Econazole Nitrate Cream 1% (DRUG), Econazole Nitrate Foam 1% (DRUG), Vehicle Foam (DRUG).
Who is sponsoring clinical trial NCT00768599?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00768599 being conducted?
This trial has 6 study locations across California, Michigan, Minnesota, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinea Pedis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
RECRUITING · Phase 2
-
Three-Arm Trial of Novel Treatment for Tinea Pedis
COMPLETED · Phase 2
-
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
COMPLETED · Phase 1
-
Spread of Dermatophytes Among Families
COMPLETED
-
BE Study of Naftifine HCL
COMPLETED · Phase 3
-
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.